Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2002

View Archived Issues

Incell develops oral smallpox vaccine

IND submitted for Tc-99m Hynic-Annexin V

Efficacy trends for DAC:Opioid in prevention of posthysterectomy pain

Nycomed acquires majority stake in Finnish joint venture

New data on the combination of unlabeled and I131-labeled tositumomab in NHL

Preliminary efficacy results reported at ASH meeting for zosuquidar in AML

Siplizumab combined with stem cell transplantation in refractory NHL

Good safety profile reported for ICA-17043 in sickle cell disease

Kytril available in oral solution for CINV and RINV

Valentis and GlaxoSmithKline expand GeneSwitch license

Incyte Genomics to become Incyte Corporation

New modulators of IL-8 and related chemokines identified by French researchers

GSK claims novel series of cathepsin K inhibitors for osteoporosis and other uses

Newly synthesized bradykinin B1 antagonists under study at Novartis

Series of protein kinase inhibitors covered by Novartis patent

Positive results for AC-2993 open-label study in type 2 diabetes

Internal analysis of European cetuximab colorectal cancer trial data at Merck KGaA

Drug pipeline for asthma

Good safety profile found for the antiepileptic drug levetiracetam in a community setting

Celecoxib filed for approval in Japan by Pharmacia and Yamanouchi

Shire seeks approval of Adderall XR in adults

Recent discovery of macrophage-inhibitory compounds by Sankyo researchers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...